Trials / Completed
CompletedNCT05826210
Effect of Sarcopenic Obesity on Weight Loss Outcomes and Quality of Life After Laparoscopic Sleeve Gastrectomy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 245 (actual)
- Sponsor
- Fujian Medical University · Academic / Other
- Sex
- All
- Age
- 16 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the impact of sarcopenic obesity (SO) on weight loss outcomes and improvement of quality of life after laparoscopic sleeve gastrectomy.
Detailed description
Sarcopenic obesity is a state in which a lack of muscle mass and strength coexists with an increase in fat mass, and it may affect the health outcome of people with obesity after laparoscopic sleeve gastrectomy (LSG).No studies have reported differences in weight loss outcomes between patients with SO and those with non-sarcopenic obesity (NSO) after LSG. Therefore, this study aimed to systematically evaluate the differences in weight loss and quality of life (QOL) evaluation between patients with SO and NSO after LSG and provide high-level evidence-based medical evidence for the impact of SO on weight loss in the obese population and refinement of follow-up strategies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Laparoscopic sleeve gastrectomy | Laparoscopic sleeve gastrectomy was performed in all patients with or without SO. |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2022-07-01
- Completion
- 2022-12-31
- First posted
- 2023-04-24
- Last updated
- 2023-04-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05826210. Inclusion in this directory is not an endorsement.